Goldman Sachs
BHVN icon

Goldman Sachs’s Biohaven BHVN Stock Holding History

Goldman Sachs’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,400
Closed -$772K – 6483
2025
Q4 		$772K Buy
68,400
+18,400
+37% +$228K ﹤0.01% 5309
2025
Q3 		$751K Buy
+50,000
New +$728K ﹤0.01% 5240

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's BHVN Position: Q1 2026 in Review

Goldman Sachs increased its Biohaven (BHVN) stake by 28% in Q1 2026, buying an estimated $6.03M and bringing the position to 2,513,181 shares worth $21.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Goldman Sachs first reported a position in BHVN in Q4 2022 and has held it in 14 quarters since. The position peaked at $51.4M in Q1 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Goldman Sachs held 2,513,181 shares of Biohaven worth $21.3M as of Q1 2026.
  • Goldman Sachs bought 550,975 Biohaven shares in Q1 2026, an estimated $6.03M.
  • Biohaven made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2376 holding.
  • Goldman Sachs first reported a position in Biohaven in Q4 2022 and has held it in 14 quarters since.
  • Goldman Sachs's Biohaven position peaked at $51.4M in Q1 2024.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.